Tizanidine Tablet
Product Images NDC 51655-603

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 51655-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 603 20 Master Bottle Label Approval Rev A 02 21)

Label for Tizanidine Tablets USP 4 mg oral tablets by Northwind Health Company, LLC. The package contains 20 tablets, Rx only. Storage instructions specify controlled room temperature (15-30°C). The label includes dosage warnings and manufacturing information from Dr. Reddy's Laboratories Limited. Additional caution notes mention that Tizanidine tablets are not interchangeable with capsules.*

FDA Label Image

Fig1 (Fig1)

A line graph depicting plasma Tizanidine concentration (ng/mL) over time (hours) post dosing at 2 x 4 mg strengths. The graph compares Tizanidine tablets and capsules taken with and without food, showing concentration changes up to 26 hours after dosing.*

FDA Label Image

Fig2 (Fig2)

A line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis indicates improvement scores, and the x-axis shows hours after dose. Data points include error bars reflecting variability.*

FDA Label Image

Fig3 (Fig3)

A line graph depicting improvement in Ashworth Score over three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The graph compares two groups labeled 'tizanidine' (mean dose 28.8 mg) and 'placebo,' showing values with error bars for each time point.*

FDA Label Image

Structure (Structure)

Chemical structure of Tizanidine hydrochloride showing its bicyclic core and attached imidazoline ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.